CN1315202A - Ointment for treating psoriasis - Google Patents

Ointment for treating psoriasis Download PDF

Info

Publication number
CN1315202A
CN1315202A CN00110973A CN00110973A CN1315202A CN 1315202 A CN1315202 A CN 1315202A CN 00110973 A CN00110973 A CN 00110973A CN 00110973 A CN00110973 A CN 00110973A CN 1315202 A CN1315202 A CN 1315202A
Authority
CN
China
Prior art keywords
ointment
realgar
camphora
alumen
dexamethasone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN00110973A
Other languages
Chinese (zh)
Other versions
CN1125645C (en
Inventor
张世刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN00110973A priority Critical patent/CN1125645C/en
Publication of CN1315202A publication Critical patent/CN1315202A/en
Application granted granted Critical
Publication of CN1125645C publication Critical patent/CN1125645C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An ointment for treating psoriasis is prepared from dexamethasone, vaseline, alcohol, dimethyl sulfoxide, and 9 Chinese medicinal materials including frankincense, myrrh, calomelas, musk, etc..

Description

Treat psoriatic ointment
The present invention relates to the psoriatic ointment of a kind of treatment.
Psoriasis is in the clinical obstinate dermatosis of a kind of comparison that is considered to.Common psoriasis has arthritis type, erythrodermic and pustule type substantially, and its performance position is on skin, and there are a large amount of antibacterials and Parakeratotic cell in the lesion.China is at present for this kind treatment of conditions mode, and general employing is based on Chinese herbal medicine for oral administration, and medicining cycle is longer, so not only quite bother, and human body is had certain side effect, but curative effect is unsatisfactory.
The objective of the invention is for solving above-mentioned insufficient section, provide a kind of treatment psoriatic ointment, it has and cures mainly in table, heavily cuts skin, to kill the comprehensive effect of pathogenic bacteria, diffusing wind-fire, clear stasis of blood poison lively atmosphere blood, foster skin, it can fundamentally cure this disease, and without any side effects to human body.
The objective of the invention is to be achieved through the following technical solutions:
Ointment of the present invention is made by following component: (consumption is a weight portion)
Olibanum 5-15, Myrrha 2-10, Calomelas 0.1-3, Moschus 2-8, sulfur 0.2-1, Camphora 2-8, Alumen 2-15, Realgar 2-9, Borneolum Syntheticum 0.2-1, dexamethasone 0.1-0.5, vaseline 40-60, ethanol 1-6, dimethyl sulfoxide 0.1-1.
Formula optimization weight (part) ratio range of making ointment of the present invention is:
Olibanum 8-12, Myrrha 4-8, Calomelas 0.6-2.5, Moschus 3-6, sulfur 0.4-0.8, Camphora 3-6, Alumen 5-12, Realgar 4-8, Borneolum Syntheticum 0.5-1, dexamethasone 0.2-0.4, vaseline 45-55, ethanol 2-5, dimethyl sulfoxide 0.4-0.8.
The optimum weight of ointment of the present invention (part) proportioning is:
Olibanum 10, Myrrha 5, Calomelas 1, Moschus 5, sulfur 1, Camphora 8, Alumen 10, Realgar 5, Borneolum Syntheticum 1, dexamethasone 0.2, vaseline 50, ethanol 3, dimethyl sulfoxide 0.4-0.8.
The production method that above-mentioned each component is made ointment of the present invention is: Olibanum is put into the alms bowl porphyrize; Myrrha is put into the alms bowl internal heating to be dissolved; Camphora, Alumen, Realgar, sulfur lump together behind the porphyrize respectively; Dexamethasone adds dimethyl sulfoxide and mixes thoroughly; The Borneolum Syntheticum dissolve with ethanol; The combustion Moschus smokes Camphora, Alumen, Realgar, sulfur fine powder in sealed container; At last above-mentioned each medicine and vaseline are stirred can bottle after even stand-by.
The clinical use result of ointment of the present invention shows that following advantage is arranged:
One, prescription is scientific and reasonable, selects for use among the present invention and draws the medicine Olibanum that bacterium goes out human body, and this medicine can activate its pathogenic bacteria, draws to make pathogenic bacteria be active in skin surface, for sterilization creates conditions;
Select medicine Alumen, the Camphora of antipruritic dissipating blood stasis among the present invention for use, it has sterilization, antipruritic, pain-relieving functions simultaneously, and the patient can remove misery fast to very itching;
Select for use Calomelas, sulfur, Realgar, Borneolum Syntheticum to form powerful germ-resistant strength among the present invention, its pathogenic bacteria of stubbornness is eliminated.In sterilization simultaneously, these several characteristic medicines also have the effect of dissolving cutin, anti-dampness, the aversion to wind of dispelling, anti-flesh corruption;
Select Moschus, Western medicine dimethyl sulfoxide among the present invention for use, antibacterial, anti-inflammatory analgetic effect is not only arranged, also have the effect of blood circulation promoting and blood stasis dispelling, thin ruton warp, regeneration skin, protection skin;
Select dexamethasone among the present invention for use, can suppress dyskeratosis, the normal perfection of protection skin prevents the skin that courses of infection is new.
Two, the present invention has broken in the mode in controlling, and it should cure mainly in the science viewpoint of table according to this sick sending out in table, has found the utilization Chinese medicine and western medicine to organically combine the active drug that kills its pathogenic bacteria and carry out scientific combination, and its curative effect is more satisfactory.
Three, the present invention has and cures mainly in table, heavily cuts skin, sterilization, the wind-fire that looses, clear stasis of blood poison lively atmosphere blood, supports the distinguishing feature of skin, and no pain, the skin that has no side effect, disease is hindered have stronger reactivation when treatment.
The present invention can also be made as water preparation.
When the present invention uses, it is spread upon patient's affected part, can cure in general 3-10 days, can effect a radical cure in weight person 10-30 days, its no pain, have no side effect, and skin is had the recovery effect.
Embodiment:
Take by weighing raw material (kilogram) by following proportioning:
Olibanum 10, Myrrha 5, Calomelas 1, Moschus 5, sulfur 1, Camphora 8, Alumen 10, Realgar 5, Borneolum Syntheticum 1, dexamethasone 0.2, vaseline 50, ethanol 3, dimethyl sulfoxide 0.4-0.8.
The production method that above-mentioned each component is made ointment of the present invention is: Olibanum is put into the alms bowl porphyrize; Myrrha is put into the alms bowl internal heating to be dissolved; Camphora, Alumen, Realgar, sulfur lump together behind the porphyrize respectively; Dexamethasone adds dimethyl sulfoxide and mixes thoroughly; The Borneolum Syntheticum dissolve with ethanol; The combustion Moschus smokes Camphora, Alumen, Realgar, sulfur fine powder in sealed container; At last above-mentioned each medicine and vaseline are stirred can bottle after even stand-by.

Claims (5)

1, the psoriatic ointment of a kind of treatment is characterized in that it is the medicament of being made by the following weight proportion raw material:
Olibanum 5-15, Myrrha 2-10, Calomelas 0.1-3, Moschus 2-8, sulfur 0.2-1, Camphora 2-8, Alumen 2-15, Realgar 2-9, Borneolum Syntheticum 0.2-1, dexamethasone 0.1-0.5, vaseline 40-60, ethanol 1-6, dimethyl sulfoxide 0.1-1.
2, the psoriatic ointment of treatment according to claim 1, wherein the weight proportion of each raw material is:
Olibanum 8-12, Myrrha 4-8, Calomelas 0.6-2.5, Moschus 3-6, sulfur 0.4-0.8, Camphora 3-6, Alumen 5-12, Realgar 4-8, Borneolum Syntheticum 0.5-1, dexamethasone 0.2-0.4, vaseline 45-55, ethanol 2-5, dimethyl sulfoxide 0.4-0.8.
3, the psoriatic ointment of treatment according to claim 1, wherein the weight proportion of each raw material is:
Olibanum 10, Myrrha 5, Calomelas 1, Moschus 5, sulfur 1, Camphora 8, Alumen 10, Realgar 5, Borneolum Syntheticum 1, dexamethasone 0.2, vaseline 50, ethanol 3, dimethyl sulfoxide 0.4-0.8.
4,, it is characterized in that said medicament is a said dosage form on any pharmaceutics according to claim 1, the psoriatic ointment of 2 or 3 described treatments.
5, the psoriatic ointment of treatment according to claim 4 is characterized in that said medicament is unguentum or water preparation.
CN00110973A 2000-03-24 2000-03-24 Ointment for treating psoriasis Expired - Fee Related CN1125645C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN00110973A CN1125645C (en) 2000-03-24 2000-03-24 Ointment for treating psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00110973A CN1125645C (en) 2000-03-24 2000-03-24 Ointment for treating psoriasis

Publications (2)

Publication Number Publication Date
CN1315202A true CN1315202A (en) 2001-10-03
CN1125645C CN1125645C (en) 2003-10-29

Family

ID=4580923

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00110973A Expired - Fee Related CN1125645C (en) 2000-03-24 2000-03-24 Ointment for treating psoriasis

Country Status (1)

Country Link
CN (1) CN1125645C (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100358547C (en) * 2003-07-10 2008-01-02 姜延德 Tinea cruris ointment
CN102406658A (en) * 2011-11-29 2012-04-11 丁荣松 Paste plaster for treating psoriasis and preparation method thereof
CN104225465A (en) * 2014-09-01 2014-12-24 郭冠良 Pharmaceutical composition for treating psoriasis and preparation method thereof
CN105687958A (en) * 2016-03-14 2016-06-22 朱克兰 Externally-used ointment for treating psoriasis and preparation method thereof
CN106362002A (en) * 2016-09-30 2017-02-01 马建国 Ointment for treatment of erythrodermic psoriasis and preparation method thereof
CN111773356A (en) * 2020-08-06 2020-10-16 辽宁宝一堂科技发展有限公司 Preparation method of plaster for treating psoriasis

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100358547C (en) * 2003-07-10 2008-01-02 姜延德 Tinea cruris ointment
CN102406658A (en) * 2011-11-29 2012-04-11 丁荣松 Paste plaster for treating psoriasis and preparation method thereof
CN104225465A (en) * 2014-09-01 2014-12-24 郭冠良 Pharmaceutical composition for treating psoriasis and preparation method thereof
CN105687958A (en) * 2016-03-14 2016-06-22 朱克兰 Externally-used ointment for treating psoriasis and preparation method thereof
CN106362002A (en) * 2016-09-30 2017-02-01 马建国 Ointment for treatment of erythrodermic psoriasis and preparation method thereof
CN111773356A (en) * 2020-08-06 2020-10-16 辽宁宝一堂科技发展有限公司 Preparation method of plaster for treating psoriasis

Also Published As

Publication number Publication date
CN1125645C (en) 2003-10-29

Similar Documents

Publication Publication Date Title
CN108853312B (en) Polycinnamic alcohol external gel and preparation method thereof
US5589480A (en) Topical application of opioid analgesic drugs such as morphine
CN101417060B (en) Plaster capable of treating trauma, traumatic injury, alopecia areata and burn and scald
CN1513476A (en) Skin-care medicine with functions of relieving-itching, fully eliminating-toxins and curing-tinea, and its prepn. method
US8492435B2 (en) Composition for treating a dermal anomaly
CN1125645C (en) Ointment for treating psoriasis
CN1927286A (en) Chinese medicine composition for treating skin disease
US5278172A (en) Method and composition for treating tendon or joint inflammation using a vasodilator
CN116870159A (en) A topical ointment for treating varicella and herpes zoster skin disease, and its preparation method
CN1055004C (en) Enternal use adhesive plaster for treatment of rheumatism
US5576329A (en) Method for treating tendon or joint inflammation with papaverine HCL
CN1079257C (en) Powder medicine for treating born and scald
CN1047080C (en) Process for preparing medicine to inhibit skin itch
CN1131067C (en) Tinea pedis eliminating medicine
CN1072499C (en) External-use medicine for curing various chronic ulcers
CN1530122A (en) Chinese medicine for treating injury
CN101940652B (en) Chinese medicinal liniment for treating psoriasis, multiple kinds of stubborn dermatitis and pruritus
CN1127970C (en) Ointment for treating burn and its preparing process
CN1261128C (en) Medicine for treating burn and scald, preparing method thereof
CN101664451B (en) Medicine for treating zona
CN1117583C (en) Medicine for curing lumbago
CN1391939A (en) External medicine for curing traumatic injuries
CN1316974C (en) Combination of medication for treating skin ulcer
CN1644204A (en) Dermitis tincture
CN1089597C (en) Psoriasis treating Chinese medicine preparation and its preparing process

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee